Centiva Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,358
| Closed | -$39.7K | – | 1703 |
|
|
2024
Q3 | $39.7K | Buy |
+23,358
| New | +$39.7K | ﹤0.01% | 1457 |
|
|
2024
Q1 | – | Sell |
-18,520
| Closed | -$182K | – | 1630 |
|
|
2023
Q4 | $182K | Buy |
+18,520
| New | +$182K | ﹤0.01% | 998 |
|
|
2022
Q4 | – | Sell |
-71,191
| Closed | -$414K | – | 1085 |
|
|
2022
Q3 | $414K | Buy |
+71,191
| New | +$414K | 0.01% | 554 |
|
|
2021
Q3 | – | Sell |
-8,736
| Closed | -$305K | – | 1162 |
|
|
2021
Q2 | $305K | Buy |
+8,736
| New | +$305K | 0.01% | 734 |
|
|
2020
Q1 | – | Sell |
-75,000
| Closed | -$386K | – | 518 |
|
|
2019
Q4 | $386K | Buy |
+75,000
| New | +$386K | 0.02% | 247 |
|